Parameters | N | ICG | MB | RI | ICG + MB | RI + ICG + MB | p |
---|---|---|---|---|---|---|---|
SLN identification rate (%) | 44 | 95.5 (42/44) | 86.4 (38/44) | 95.5 (42/44) | 95.5 (42/44) | 100 (44/44) | 0.068b |
SLN counts (median (IQR)) | 44 | 3 (1) | 2 (2) | 2 (1) | 3 (1) | 3 (1) | < 0.0001c |
False-negative rate (%) | 11 | 0 (0/11) | 18.2 (2/11) | 18.2 (2/11) | 0 (0/11) | 0 (0/11) | 0.2b |
Sensitivity (%) | 11 | 100 (11/11) | 81.8 (9/11) | 81.8 (9/11) | 100 (11//11) | 100 (11/11) | 0.2b |
Metastatic SLN rate (%) | 44 | 25 (11/44) | 20.5 (9/44) | 20.5 (9/44) | 25 (11/44) | 25 (11/44) | 0.962a |
Metastatic SLN counts (median (IQR)) | 11 | 2 (4) | 1 (1) | 1 (1) | 2 (4) | 2 (4) | 0.101c |